Ibex [IBEX] vs International [IBM] Detailed Stock Comparison

Ibex

International
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ibex wins in 9 metrics, International wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | Ibex | International | Better |
---|---|---|---|
P/E Ratio (TTM) | 18.50 | 40.81 | Ibex |
Price-to-Book Ratio | 3.86 | 8.58 | Ibex |
Debt-to-Equity Ratio | 51.94 | 245.47 | Ibex |
PEG Ratio | 15.60 | 2.20 | International |
EV/EBITDA | 8.68 | 20.34 | Ibex |
Profit Margin (TTM) | 6.60% | 9.11% | International |
Operating Margin (TTM) | 9.69% | 18.32% | International |
EBITDA Margin (TTM) | 9.69% | 18.32% | International |
Return on Equity | 24.57% | 22.67% | Ibex |
Return on Assets (TTM) | 10.71% | 4.81% | Ibex |
Free Cash Flow (TTM) | $27.05M | $11.76B | International |
Dividend Yield | N/A | 1.77% | N/A |
1-Year Return | 110.42% | 21.73% | Ibex |
Price-to-Sales Ratio (TTM) | 1.00 | 3.69 | Ibex |
Enterprise Value | $571.70M | $288.44B | International |
EV/Revenue Ratio | 1.02 | 4.50 | Ibex |
Gross Profit Margin (TTM) | N/A | 58.77% | N/A |
Revenue per Share (TTM) | $38 | $69 | International |
Earnings per Share (Diluted) | $2.10 | $6.21 | International |
Beta (Stock Volatility) | 0.77 | 0.70 | International |
Ibex vs International Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Ibex | 4.04% | 37.89% | 44.28% | 48.62% | 68.13% | 93.55% |
International | 2.29% | 3.11% | 10.67% | -6.43% | 7.31% | 20.49% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Ibex | 110.42% | 151.50% | 205.45% | 172.73% | 172.73% | 172.73% |
International | 21.73% | 115.96% | 133.03% | 90.62% | 106.69% | 255.37% |
News Based Sentiment: Ibex vs International
Ibex
News based Sentiment: POSITIVE
IBEX delivered a substantial earnings surprise, leading to a dramatic stock price increase and positive analyst revisions. The company's strategic shift towards AI and digital transformation is gaining momentum, positioning it for future growth. This month represents a significant positive shift in the investment narrative.
International
News based Sentiment: POSITIVE
IBM delivered a strong Q2 earnings report, exceeding expectations and reaffirming its full-year guidance. The continued growth of its AI business is a significant positive, though some market headwinds and insider selling create a mixed picture. Overall, the month points to a positive trajectory for the company.
Performance & Financial Health Analysis: Ibex vs International
Metric | IBEX | IBM |
---|---|---|
Market Information | ||
Market Cap | $556.60M | $236.08B |
Market Cap Category | Small cap | Mega cap |
10 Day Avg. Volume | 296,930 | 4,157,680 |
90 Day Avg. Volume | 154,447 | 4,785,297 |
Last Close | $42.00 | $265.00 |
52 Week Range | $17.53 - $42.99 | $203.51 - $296.16 |
% from 52W High | -2.30% | -10.52% |
All-Time High | $42.99 (Sep 12, 2025) | $296.16 (Jun 25, 2025) |
% from All-Time High | -2.30% | -10.52% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.18% | 0.08% |
Quarterly Earnings Growth | -0.03% | 0.20% |
Financial Health | ||
Profit Margin (TTM) | 0.07% | 0.09% |
Operating Margin (TTM) | 0.10% | 0.18% |
Return on Equity (TTM) | 0.25% | 0.23% |
Debt to Equity (MRQ) | 51.94 | 245.47 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $10.06 | $29.53 |
Cash per Share (MRQ) | $1.15 | $16.58 |
Operating Cash Flow (TTM) | $45.67M | $13.28B |
Levered Free Cash Flow (TTM) | $27.12M | $13.86B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 1.77% |
Last 12-Month Dividend | N/A | $5.01 |
Valuation & Enterprise Metrics Analysis: Ibex vs International
Metric | IBEX | IBM |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 18.50 | 40.81 |
Forward P/E | 15.60 | 23.89 |
PEG Ratio | 15.60 | 2.20 |
Price to Sales (TTM) | 1.00 | 3.69 |
Price to Book (MRQ) | 3.86 | 8.58 |
Market Capitalization | ||
Market Capitalization | $556.60M | $236.08B |
Enterprise Value | $571.70M | $288.44B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.02 | 4.50 |
Enterprise to EBITDA | 8.68 | 20.34 |
Risk & Other Metrics | ||
Beta | 0.77 | 0.70 |
Book Value per Share (MRQ) | $10.06 | $29.53 |
Financial Statements Comparison: Ibex vs International
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | IBEX | IBM |
---|---|---|
Revenue/Sales | $140.74M | $16.98B |
Cost of Goods Sold | $96.02M | $7.00B |
Gross Profit | $44.72M | $9.98B |
Research & Development | N/A | $2.10B |
Operating Income (EBIT) | $13.33M | $3.09B |
EBITDA | $17.69M | $4.54B |
Pre-Tax Income | $12.96M | $2.60B |
Income Tax | $2.49M | $404.00M |
Net Income (Profit) | $10.47M | $2.19B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | IBEX | IBM |
---|---|---|
Cash & Equivalents | $12.98M | $11.04B |
Total Current Assets | $148.66M | $35.34B |
Total Current Liabilities | $89.01M | $35.11B |
Long-Term Debt | $57.68M | $59.12B |
Total Shareholders Equity | $124.18M | $26.95B |
Retained Earnings | $16.15M | $150.70B |
Property, Plant & Equipment | $96.21M | $21.15B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | IBEX | IBM |
---|---|---|
Operating Cash Flow | $13.44M | $2.63B |
Capital Expenditures | $-5.27M | $-170.00M |
Free Cash Flow | $3.56M | $3.98B |
Debt Repayment | $-48.84M | $-1.26B |
Common Stock Repurchase | $-25.05M | $-284.00M |
Short Interest & Institutional Ownership Analysis
Metric | IBEX | IBM |
---|---|---|
Shares Short | 127,553 | 14.28M |
Short Ratio | 1.48 | 2.86 |
Short % of Float | 0.02% | 0.02% |
Average Daily Volume (10 Day) | 296,930 | 4,157,680 |
Average Daily Volume (90 Day) | 154,447 | 4,785,297 |
Shares Outstanding | 17.02M | 926.29M |
Float Shares | 10.12M | 929.40M |
% Held by Insiders | 0.13% | 0.00% |
% Held by Institutions | 0.95% | 0.65% |
Dividend Analysis & Yield Comparison: Ibex vs International
Metric | IBEX | IBM |
---|---|---|
Last 12-Month Dividend | N/A | $5.01 |
Last 12-Month Dividend Yield | N/A | 1.77% |
3-Year Avg Annual Dividend | N/A | $6.09 |
3-Year Avg Dividend Yield | N/A | 1.04% |
3-Year Total Dividends | N/A | $18.27 |
Ex-Dividend Date | N/A | Feb 10, 2025 |